Market Price Risk Relating to Securities and Investment Securities
First written in FY2017. 11 of 28 entries say "Worsened", first in FY2018. Latest entry: FY2026.
ODK Solutions Company moved to the "Worse" side of this theme in 2024, 5 years after the typical company in this theme (2019).
The whole theme swung hardest in 2019: 54 of 136 companies on the "Worse" side.
15 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「Marketable securities 1,183,723 1,236,607」
The balance of marketable securities increased from ¥1,183.723 million to ¥1,236.607 million, increasing balance-sheet exposure to market price fluctuations. - 2026-04-30WorsenedRevision of earnings forecasts
「Investment securities 1,183,723 1,236,607」
The balance of investment securities increased from the end of the previous consolidated fiscal year, expanding balance-sheet exposure to market-price movements. - FY2026-H1WorsenedAnnual report
「Marketable securities 1,183,723 1,285,619」
The balance of marketable securities increased from ¥1,183.723 million at the end of the previous fiscal year to ¥1,285.619 million, increasing balance-sheet exposure to market price fluctuations. - FY2025WorsenedAnnual report
「Marketable securities 1,064,512 1,183,723」
The balance of marketable securities increased from ¥1,064.512 million to ¥1,183.723 million, increasing balance-sheet exposure to market price fluctuations. - FY2024MaterialisedAnnual report
「During the fiscal year, impairment losses of ¥6.673 million were recognized on securities, comprising ¥6.673 million on unlisted shares classified as other securities.」
An impairment loss of ¥6.673 million was recognized on the unlisted shares held, meaning the decline in market price or fair value was reflected in earnings. - FY2024-Q3WorsenedAnnual report
「Marketable securities 978,678 1,099,697」
The balance of marketable securities increased from ¥978.678 million at the end of the previous fiscal year to ¥1,099.697 million, increasing balance-sheet exposure to market price fluctuations. - FY2024-Q2RestatedAnnual report
「The amounts recorded for marketable securities on the quarterly consolidated balance sheet and other amounts showed no material change compared with the end of the previous consolidated fiscal year.」
The company stated that there had been no material change in marketable securities and investment securities compared with the end of the previous consolidated fiscal year. - FY2024-Q1WorsenedAnnual report
「Marketable securities 978,678 1,006,740」
The balance of marketable securities increased from ¥978.678 million at the end of the previous fiscal year to ¥1,006.740 million, increasing balance-sheet exposure to market price fluctuations. - FY2023MitigatedAnnual report
「Marketable securities 1,029,402 978,678」
The balance of marketable securities decreased from ¥1,029.402 million at the end of the previous fiscal year to ¥978.678 million, reducing balance-sheet exposure to market price fluctuations. - FY2023-Q3MitigatedAnnual report
「Marketable securities 1,029,402 1,012,161」
The balance of marketable securities decreased from ¥1,029.402 million at the end of the previous fiscal year to ¥1,012.161 million, reducing balance-sheet exposure to market price fluctuations. - FY2023-Q2RestatedAnnual report
「The amounts recorded for marketable securities on the quarterly consolidated balance sheet and other amounts showed no material change compared with the end of the previous consolidated fiscal year.」
The company stated that there had been no material change in marketable securities and investment securities compared with the end of the previous consolidated fiscal year. - FY2023-Q1MitigatedAnnual report
「Investment securities 1,482,390 1,029,402」
The balance of investment securities declined from ¥1,482.390 million at the end of the previous consolidated fiscal year to ¥1,029.402 million, reducing exposure to fluctuations in market prices in terms of the balance held. - FY2022MaterialisedAnnual report
「The amount declined by ¥246.197 million from the end of the previous consolidated fiscal year to ¥8,030.087 million, mainly due to a decline in investment securities resulting from the fair-value measurement of shares held and other factors.」
Investment securities declined due to fair-value measurement and other factors, while the valuation difference on available-for-sale securities also declined by ¥247.645 million, affecting net assets. - FY2022-Q3MaterialisedAnnual report
「Investment securities 1,482,390 1,118,121 Valuation difference on available-for-sale securities △ 7,415 △ 185,851」
The balance of investment securities declined from ¥1,482.390 million to ¥1,118.121 million, while the valuation difference on available-for-sale securities declined by ¥185.851 million, reflecting the impact of fluctuations in market prices in net assets. - FY2022-Q2RestatedAnnual report
「The amounts recorded for marketable securities on the quarterly consolidated balance sheet and other amounts showed no material change compared with the end of the previous consolidated fiscal year.」
The company stated that there had been no material change in marketable securities and investment securities compared with the end of the previous consolidated fiscal year. - FY2022-Q1MitigatedAnnual report
「Investment securities 1,482,390 1,400,226」
The balance of investment securities declined from ¥1,482.390 million at the end of the previous consolidated fiscal year to ¥1,400.226 million, reducing exposure to fluctuations in market prices in terms of the balance held. - FY2021MitigatedAnnual report
「Investment securities 1,674,054 1,482,390」
The balance of investment securities declined from ¥1,674.054 million at the end of the previous fiscal year to ¥1,482.390 million, reducing exposure to fluctuations in market prices in terms of the balance held. - FY2021-Q3MitigatedAnnual report
「Investment securities 1,674,054 1,653,980」
The balance of investment securities declined from ¥1,674.054 million at the end of the previous consolidated fiscal year to ¥1,653.980 million, reducing exposure to fluctuations in market prices in terms of the balance held. - FY2021-Q1MaterialisedAnnual report
「Net assets declined by ¥302.318 million from the end of the previous consolidated fiscal year to ¥5,294.553 million, mainly due to a decline in the valuation difference on available-for-sale securities.」
The valuation difference on available-for-sale securities declined, causing net assets to decrease by ¥302.318 million from the end of the previous consolidated fiscal year. The risk of fluctuations in market prices has actually affected net assets through the valuation difference. - FY2020WorsenedAnnual report
「Investment securities 1,303,624 1,674,054」
The balance of investment securities increased from ¥1,303.624 million at the end of the previous consolidated fiscal year to ¥1,674.054 million, expanding exposure to fluctuations in market prices. - FY2020-Q3WorsenedAnnual report
「Investment securities 1,303,624 1,768,344」
The balance of investment securities increased from ¥1,303.624 million at the end of the previous consolidated fiscal year to ¥1,768.344 million at the end of the third quarter under review, expanding exposure to fluctuations in market prices. - FY2020-Q2RestatedAnnual report
「The amounts recorded for marketable securities on the quarterly consolidated balance sheet and other amounts showed no material change compared with the end of the previous consolidated fiscal year.」
The company stated that there had been no material change in the risk of fluctuations in the market prices of marketable securities and investment securities compared with the end of the previous consolidated fiscal year. - FY2019MaterialisedAnnual report
「Net income attributable to owners of the parent increased by ¥48.898 million from the previous consolidated fiscal year to ¥307.543 million, up 18.9% year on year, mainly due to the recognition of an impairment loss on investment securities.」
An impairment loss of ¥97.986 million on investment securities was recognized, and the decline in market prices and fair value was reflected in earnings. - FY2019-Q3MitigatedAnnual report
「Investment securities 1,414,235 1,268,382」
The balance of investment securities declined from ¥1,414.235 million at the end of the previous consolidated fiscal year to ¥1,268.382 million at the end of the third quarter under review, reducing exposure to fluctuations in market prices in terms of the balance held. - FY2019-Q2WorsenedAnnual report
「Investment securities 1,414,235 1,558,858」
The balance of investment securities increased from ¥1,414.235 million at the end of the previous consolidated fiscal year to ¥1,558.858 million at the end of the second quarter under review, expanding exposure to fluctuations in market prices. - FY2019-Q1WorsenedAnnual report
「Investment securities 1,414,235 1,475,651」
The balance of investment securities increased from ¥1,414.235 million at the end of the previous consolidated fiscal year to ¥1,475.651 million at the end of the first quarter under review, expanding exposure to fluctuations in market prices. - FY2018WorsenedAnnual report
「Marketable securities and investment securities consist mainly of shares in companies with which the company has business relationships and investment trusts, and are exposed to the risk of fluctuations in market prices.」
The balance of marketable securities and investment securities increased from ¥925.989 million in the previous fiscal year to ¥1,414.235 million, expanding exposure to fluctuations in market prices. - FY2017First statedAnnual report
「Marketable securities and investment securities consist mainly of shares in companies with which the company has business relationships and investment trusts, and are exposed to the risk of fluctuations in market prices.」
Investment securities totaled ¥925.989 million at the end of the consolidated fiscal year, and exposure to fluctuations in market prices was newly identified as a risk.